> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Agency Says Firm Submitted Invalid Data
- URL: https://www.fdaweb.com/agency-says-firm-submitted-invalid-data/
- Published: 2026-06-25T12:00:00.000Z
- Updated: 2026-09-14T13:41:58.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5161374

FDA says that based on its data analyses, it has determined that CCIC Huatongwei International Inspection (Suzhou) Co., Ltd., in Suzhou, Jiangsu Province, China, has, in several instances, copied the results of another study or created falsified or otherwise invalid medical device data that were submitted to the agency. “Until the firm adequately addresses these issues,” an FDA [notice](https://www.fda.gov/medical-devices/industry-medical-devices/notifications-data-integrity-medical-devices?utm%5Fmedium=email&utm%5Fsource=govdelivery) says, “all study data from all studies conducted at this testing facility will be rejected.”

The notice reminds medical device manufacturers and trial sponsors to carefully evaluate the third parties they engage to conduct safety, performance, and cybersecurity testing, and to independently verify all testing results before submitting them to the agency.